Export für Ihre Literaturverwaltung

Übernahme per Copy & Paste
Bibtex-Export
Endnote-Export

       

Weiterempfehlen

Bookmark and Share


Supranational regulatory agencies between independence and control : the EMEA and the authorization of pharmaceuticals in the European Single Market

[Zeitschriftenartikel]

Gehring, Thomas; Krapohl, Sebastian

Zitationshinweis

Bitte beziehen Sie sich beim Zitieren dieses Dokumentes immer auf folgenden Persistent Identifier (PID):http://nbn-resolving.de/urn:nbn:de:0168-ssoar-130683

Weitere Angaben:
Abstract "The European Medicines Agency (EMEA) represents a new type of supranational regulation. Formally, it merely advises the Commission and a member state committee on the authorization of pharmaceuticals. In practice, however, it dominates decision-making and operates much like an independent agency. Based upon a brief discussion of the merits of independent regulation and the necessity to control regulatory activities, the article explores the institutional arrangement in which the EMEA is embedded and seeks to explain how tight oversight is compatible with quasi-independent action. It argues that the multi-tiered oversight mechanism restricts the non-scientific actors involved in the authorization of pharmaceuticals more than the agency – as long as the agency adheres to its mandate of producing scientifically convincing decisions." (author's abstract)
Thesaurusschlagwörter pharmaceutical industry; regulation; control; pharmaceutical; delegation of tasks
Klassifikation Europapolitik
Freie Schlagwörter EMEA; pharmaceuticals; regulatory agencies; Single Market regulation
Sprache Dokument Englisch
Publikationsjahr 2007
Seitenangabe S. 208-226
Zeitschriftentitel Journal of European Public Policy, 14 (2007) 2
DOI http://dx.doi.org/10.1080/13501760601122407
Status Veröffentlichungsversion; begutachtet
Lizenz Deposit Licence - Keine Weiterverbreitung, keine Bearbeitung
Datenlieferant Dieser Metadatensatz wurde vom Sondersammelgebiet Sozialwissenschaften (USB Köln) erstellt.
top